COVID-19 patients on remdesivir had 31% faster recovery — trial shows

Patients who were hospitalized with advanced COVID-19 and breathing problems recovered faster on antiviral drug remdesivir than similar patients on a placebo, according to preliminary data from a large US-led trial.

“Preliminary results indicate that patients who received remdesivir had a 31 percent faster time to recovery than those who received placebo,” says the US National Institute of Allergy and Infectious Diseases in a statement.


Most Popular